Floatz logo

Risperidone

Manic Bipolar Affective Disorder

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Small moleculePhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Manic Bipolar Affective Disorder cohort.

Asset / SponsorPhaseRating
LITHIUM, ELEMENTAL
University of Cincinnati
Phase 4BBB
QUETIAPINE
University of Cincinnati
Phase 4BBB
Brexpiprazole
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
LAMOTRIGINE
Medical University of South Carolina
Phase 4BB
Allopurinol
Sheba Medical Center
Phase 4BB

View all 27 →

Same molecule, other indications

Risperidone is also rated in:

major depressive disorderDormant
BBB
Indicative ·
78 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
77 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →